Detalhe da pesquisa
1.
Alkaline phosphatase treatment of acute kidney injury - an update.
Nephrol Dial Transplant
; 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400561
2.
Alkaline phosphatase to treat ischaemia-reperfusion injury in living-donor kidney transplantation: APhIRI I feasibility pilot study.
Br J Clin Pharmacol
; 89(12): 3629-3636, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37548047
3.
Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies.
Rheumatology (Oxford)
; 57(3): 555-562, 2018 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029294
4.
Clinical and genetic analyses of a Dutch cohort of 40 patients with a nephronophthisis-related ciliopathy.
Pediatr Nephrol
; 33(10): 1701-1712, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29974258
5.
Daratumumab for multidrug-resistant phospholipase-A2 receptor-related membranous nephropathy.
Kidney Int
; 101(3): 646-647, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35190038
6.
Relation between duration of the prodromal phase and renal damage in ANCA-associated vasculitis.
BMC Nephrol
; 18(1): 378, 2017 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29287588
7.
Prevalence and management of cardiovascular risk factors in ANCA-associated vasculitis.
Rheumatology (Oxford)
; 58(12): 2333-2335, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243446
8.
Efficacy of Alkaline Phosphatase in Critically Ill Patients with COVID-19: A Multicentre Investigator-Initiated Double-Blind Randomised Placebo-Controlled Trial.
Biomedicines
; 12(4)2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672081
9.
Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study.
Kidney Int Rep
; 8(1): 91-102, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644349
10.
Inactivating PSMB5 mutations and P-glycoprotein (multidrug resistance-associated protein/ATP-binding cassette B1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno)proteasome inhibitors in mononuclear blood cells from patients with rheumatoid arthritis.
J Pharmacol Exp Ther
; 341(1): 174-82, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22235146
11.
Outcome of atypical haemolytic uraemic syndrome relapse after eculizumab withdrawal.
Clin Kidney J
; 14(8): 1939-1945, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34631043
12.
Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein.
Blood
; 112(6): 2489-99, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18565852
13.
Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis.
Lupus Sci Med
; 2(1): e000121, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719810
14.
ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer.
J Leukoc Biol
; 86(5): 1075-87, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19745159
15.
Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.
Arthritis Rheum
; 60(1): 12-21, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19116913
16.
Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide.
Arthritis Rheum
; 60(3): 669-77, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19248091
17.
Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography.
Arthritis Rheum
; 58(11): 3350-5, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18975347
18.
Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside.
Nat Clin Pract Rheumatol
; 3(1): 26-34, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17203006